Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study

Clinical trial NCT06728852 · RECRUITING

Trial details

NCT number

NCT06728852

Sponsor

Li-kun Chen

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-12-01

Primary completion

2026-12-01

Enrollment

32

View on ClinicalTrials.gov